Rats subjected to bilateral common carotid artery (CCA) occlusion or 2-vessel occlusion (2VO) have been used as animal models of subcortical ischemic vascular dementia. However, this model possesses an inherent limitation in that cerebral blood flow (CBF) drops too sharply and substantially after ligation of CCAs. To circumvent such hypoxic-ischemic conditions, we tested to implant the ameroid constrictor device on bilateral CCAs of male Wistar-Kyoto rats and more precisely replicated chronic cerebral hypoperfusion by gradual narrowing of the CCAs (2-vessel gradual occlusion; 2VGO). The acute CBF reduction and resultant inflammatory responses observed in the 2VO rats were eliminated in the 2VGO rats. Thus, chronic cerebral hypoperfusion was segregated, and induced selective white matter changes with relatively preserved neurovascular coupling and substantially less metabolic and histological derangements in the gray matter including the hippocampus. This led to significant spatial working memory impairment of a similar magnitude to the 2VO rats at 28 days post-operation.
Introduction
Vascular dementia (VaD) is the second most common cause of dementing illnesses after
Alzheimer's disease (AD) . Approximately half of all cases of VaD are explained by subcortical ischemic vascular dementia (SIVD) (Yoshitake et al., 1995) , which is characterized by lacunar infarctions in the basal ganglia and ischemic white matter changes. Loss of vasomotor reactivity in the small vessels and resultant chronic cerebral hypoperfusion with blood-brain barrier (BBB) disruption and glial activation may underlie the white matter changes (Marshall and Lazar, 2011; Pantoni, 2010) .
To mimic such a pathological condition and explore the underlying mechanisms, several animal models of chronic cerebral hypoperfusion have been developed, including bilateral common carotid artery (CCA) or 2-vessel occlusion (2VO) in rats, bilateral CCA stenosis in gerbils or mice (BCAS) (Shibata et al., 2004) and unilateral CCA occlusion in mice (Yoshizaki et al., 2008) . Among these, the rat 2VO model has been frequently used (Jiwa et al., 2010) and may become more important once genetically-modified rats are widely available. The 2VO model exhibits characteristic features of SIVD, such as white matter damage (Wakita et al., 1994; Wakita et al., 2002) , and cognitive impairment (Farkas et al., 2007; Hainsworth and Markus, 2008; Jiwa et al., 2010) . Nevertheless, this model possesses an inherent limitation in that cerebral blood flow (CBF) drops too sharply and substantially after the ligation of the CCAs and remains too low (30-45% of the baseline level) for 2-3 days; this therefore creates hypoxic-ischemic conditions too severe to replicate 'chronic' cerebral hypoperfusion (Marosi et al., 2006) . Following this acute phase, CBF gradually recovers but still remains relatively low (50-90%) for 8 weeks to 3 months post-operation (chronic phase) (Otori et al., 2003; Tomimoto et al., 2003) . Although the sustained oligemia in the chronic phase is believed to better replicate chronic cerebral hypoperfusion associated with SIVD, the contribution of the preceding acute phase to the neuropathological and behavioral consequences is an ongoing concern (Farkas et al., 2007) . We therefore sought to establish a novel rat model that eliminates the acute phase, meaning that CBF would gradually decrease to the level in the chronic phase, using the ameroid constrictor device. This device could predictably achieve gradual narrowing of the CCAs and establish a rat model of SIVD that replicates 'chronic' cerebral hypoperfusion more precisely.
We therefore henceforth refer to this novel rat model as the '2-vessel gradual occlusion (2VGO)' model.
Materials and Methods

1. Animals
We used 12-to 14-week-old male Wistar-Kyoto rats (WKY) (See Supplemental Method I for details).
Under anesthesia, the 2VGO rats were subjected to surgical implantation of ameroid constrictors on the CCAs bilaterally whereas in the 2VO group, both the CCAs were ligated (Supplemental Method III).
5. Computed tomography-angiography
CTA of the bilateral CCAs was repeatedly performed under anesthesia using the R_mCT system (Rigaku, Tokyo, Japan) (Supplemental Method IV).
6. Cerebral blood flow, blood pressure and pulse rate measurement
CBF in the frontal cortices was recorded by LSF under anesthesia with isoflurane (1.5%) (Supplemental Method V).
7. 18 F-FDG PET acquisition and image analysis
Small animal PET imaging was performed to assess temporal changes in 18 F-FDG uptake during the first 5 minutes and again between 45 and 90 minutes (Supplemental Method VI).
8. Histological evaluation of demyelinating changes and glial activation
Paraffin-embedded coronal sections of the brain (6 μm-thick) were analyzed with hematoxylin-eosin (HE) staining for detection of infarcted areas in the forebrain and for neurodegeneration in the hippocampal CA1 and CA3 regions, and with Klüver-Barrera staining for demyelinating changes. The severity of the white matter lesions in the optic chiasma, medial and lateral parts of the corpus callosum and caudoputamen, was graded as normal (Grade 0), disarrangement of the nerve fibers (Grade 1), the formation of marked vacuoles (Grade 2) and the disappearance of myelinated fibers (Grade 3), according to the established criteria (Wakita et al., 1994) . They were also immunostained for ionized calcium binding adaptor molecule-1 (Iba-1; a marker of microglia; Wako, Osaka, Japan), glial fibrillary acidic protein (GFAP; astrocyte; DAKO, Glostrup, Denmark), glutathione S-transferase-π (GST-π; oligodendrocyte;
Assay Designs, Ann Arbor, MI, USA), degraded MBP (dMBP; demyelinating changes; a gift from Dr. Wakita) (Ihara et al., 2010) and myelin-associated glycoprotein (MAG; Santa Cruz Biotechnology, CA, USA) (Supplemental Method VII).
9. Quantitative real-time reverse transcriptase-polymerase chain reaction
Cerebral mRNA levels of the monocyte chemoattractant protein-1 (MCP-1) and tumor necrosis factor-α (TNF-α) were assessed by quantitative real-time RT-PCR (Supplemental Method VIII).
10 Enzyme-Linked Immunosorbent Assay (ELISA) for TNF-α
The protein concentration of TNF-α in brain homogenates were also measured using a specific ELISA kit according to the manufacturer's recommendation (R&D systems, Minneapolis, MN, USA) (Supplemental Method IX).
11. Western blotting analysis for myelin basic protein
The optic nerves and chiasma were analyzed for demyelinating changes. A rabbit anti-MBP antibody and a mouse anti β-actin antibody (which served as an internal control), were used (Supplemental Method X).
1Y-maze test for spatial working memory assessment
Spatial working memory was assessed by the Y-maze test (Supplemental Method XI).
13. Statistical analysis
All values are expressed as mean±SEM. One-way analysis of variance was used to evaluate significant differences among groups (except where otherwise stated) followed by a post hoc Tukey test or Tukey-Kramer test. Differences with P<0.05 were considered significant in all statistical analyses.
Results
1. Mortality rates and body weight changes of rats
The mortality rate in the 2VGO group was 2.0% (1/49). This was much lower than that of the 2VO group, which was 13.8% (8/58), in accordance with previous reports (Fujishima et al., 1976) . In the sham group, all of 48 rats survived until euthanized. Body weight decreased in both the 2VGO and 2VO groups, which was significantly less severe in the 2VGO group at 1 day post-operation (2VGO group, -14.1±2.0% vs. 2VO group, -27.4±1.7%; P<0.01). Both groups of rats started to regain body weight at 3 days.
2. Gradual narrowing of the common carotid arteries
Bilateral placement of the ameroid constrictors on the CCAs produced the expected narrowing of the inner lumen: 0.28 mm at 1 day post-operation, 0.24 mm at 3 days and 0.19 mm at 5 days ( Fig. 1B and C) . CTA indicated that blood flow of CCAs distal to the implanted ameroid constrictors did not decrease at 1 hour but started to decrease at 3 hours, leading to complete occlusion of the CCAs at 3 days (Fig. 3) .
Temporal profiles of CBF recorded by LSF
In the 2VO group, CBF dropped sharply to 55.2±0.8% of the baseline level at 3 hours post-operation but started to recover at 3 days and reached to 85.6±3.7% at 28 days. In contrast, in the 2VGO group, the acute phase observed in the 2VO group was absent; CBF did not decrease at 1 hour (102.5±2.9%) but started to decrease at 3 hours (79.6±3.3%), and reached a minimum at 3 days (69.3±1.7%), before gradually recovering at 28 days (84.5±3.3%). In the sham group, no apparent change of CBF was detected. Two-way repeated-measures analysis of variance showed a significant interaction between group and time (F(14, 63)=16.976, P<0.001) and significant differences between the 2VGO and 2VO groups at 1, 3 and 6 hours and 1 day ( Fig. 4A and B) .
The blood pressure and pulse rate of the surviving rats did not differ significantly among the three groups at any postoperative intervals until 28 days.
4. 18 F-FDG PET analysis
The first 5-minute uptake of 18 F-FDG, which was used as an indicator of CBF, showed a similar temporal profile of the CBF recorded by LSF: the uptake dropped more substantially in the 2VO than 2VGO groups at 3 hours post-operation but recovered at 28 days in the both groups (Fig. 5A ).
The late 18 F-FDG uptake, used as an indicator of cerebral glucose metabolism, did not significantly decrease at 28 days in the 2VGO group. Whereas, in the 2VO group at 28 days, late 18 F-FDG uptake significantly decreased in the cerebral cortex compared to that in the 2VGO group and in the hippocampus compared to pre-operation (Fig. 5B) .
5. Y-maze test for spatial working memory assessment
In the 2VGO and 2VO groups, the percentage of alternation behaviors (used as a reflection of spatial working memory) was significantly decreased (Fig. 6A) , whereas the number of arm entries was significantly increased, compared with the sham group at 28 days (Fig. 6B) .
6. Histological analysis of gray matter damage
Brain infarcted areas were not found in any rats of the 2VGO and sham groups but in 50% of rats in the 2VO group at 3, 14 and 28 days (Supplemental Fig. 1A ). The infarctions were distributed mainly in the caudoputamen. Cortical gliosis was not found in the sham group and was present in only 8.3% of rats in the 2VGO group at 3, 14 and 28 days ( Supplemental Fig. 1B ); however, cortical gliosis was present in 75% of rats in the 2VO group over the same periods. There was a trend toward increased density of pyknotic neurons in the hippocampal CA1 region at 28 days in the 2VO group compared to the 2VGO and sham groups ( Supplemental Fig. 1C) ; however, there were no significant differences in density among the three groups.
7. Histological analysis of white matter damage
Quantitative analysis of the grading score of Klüver-Barrera staining of the corpus callosum indicated that the white matter damage was significantly more severe in both the 2VGO and 2VO groups compared with the sham group at 28 days post-operation; however, the extent of damage was significantly smaller in the 2VGO compared to 2VO groups (Fig. 7A ).
Similar findings in the degree of myelin damage (assessed by dMBP staining) (Fig. 7B ) and the density of GST-π-positive oligodendrocytes (Fig. 7C) were discovered: the white matter damage was slightly milder in the 2VGO compared to the 2VO groups but was still more severe than the sham group. In the 2VGO and 2VO groups, MAG-immunopositive regions (indicating the degree of axon-glial integrity) decreased compared to the sham group, with the most apparent difference at 28 days (data not shown). The density of GFAP-immunopositive astrocytes was significantly greater in both the 2VGO and 2VO groups compared to the sham group at 28 days (data not shown). The density of Iba-1-immunopositive microglia increased from 1 day in the
Discussion
The findings in this study suggest circumvention of the acute phase of CBF reduction and resultant acute inflammatory response observed in the 2VO model by gradual narrowing of the bilateral CCAs using the ameroid constrictor device instead of ligation. As a result, segregation of the chronic phase from the acute phase was achieved, suggesting a more precise reconstruction of chronic cerebral hypoperfusion evident in clinical cases of SIVD. This method induced demyelinating changes with inflammatory and glial responses but without apparent infarcted lesions or pronounced metabolic derangement in the gray matter. White matter changes were substantial in both the 2VGO and 2VO groups but significantly less severe in the 2VGO group. This suggests that the neuropathological consequences and metabolic changes of the 2VO model had been generated not only by chronic cerebral hypoperfusion but also by acute drop in CBF immediately after bilateral CCAs occlusion. The differences in mortality rate, infarction rate and body weight loss between the 2VGO and 2VO groups may reflect gradual CBF reduction in the 2VGO group.
Y-maze tests showed significant spatial working memory impairment in both the 2VGO and 2VO groups. The spatial working memory impairment in the 2VGO model may be derived from white matter damage because neuropathological changes and glucose hypometabolism
were not apparent in the cortex and hippocampus at 28 days. By contrast, the 2VO model exhibited persistent metabolic derangement in the gray matter at 28 days, despite CBF recovery; this suggests neurovascular uncoupling even at 28 days post-operation. The 2VO and 2VGO model may thus be defined by the presence or absence of the acute CBF drop, respectively; therefore, the persistent neurovascular uncoupling at 28 days in the 2VO group may result from the ischemic insult applied to the brain in the acute phase post-operation. These results therefore
suggest that the 2VGO model may more closely replicate the condition of working memory impairment subsequent to ischemic white matter changes.
The reasons as to why the 2VGO model showed comparable spatial working memory impairment to the 2VO model may be explained by the fact that less pronounced white matter damage was sustained in the 2VGO model compared to the 2VO model where the damage was sufficient to induce spatial working memory impairment detected by the Y-maze test. Another reason may be the impaired glial-axon integrity (assessed with MAG immunostaining) (Quarles, 2007) , which was comparable between 2VGO and 2VO models; this therefore may have contributed to the working memory impairment.
No single animal model appears to recapitulate all the features of SIVD as humans have different brain anatomy and longer perforating arteries. In addition, the current model lacks vascular risk factors and causative small vessel changes that may lead to alterations in blood flow and cerebral autoregulation. One of the ways to resolve this problem could be to implant ameroid constrictors in spontaneous hypertensive rats (SHR). However, SHRs subjected to the bilateral CCA occlusion have shown more extensive CBF reduction accompanied by more extensive cerebral infarcts and demyelinating changes and higher mortality rate (72%; 78 of 108) than the corresponding normotensive counterpart WKY rats (16%; 7 of 43) (Fujishima et al., 1976; Ogata et al., 1976) . Beside the high mortality, such severe CBF reduction with marked infarctions may not adequately represent SIVD. Our preliminary data showed that the mortality rate of SHRs subjected to implantation of ameroid constrictors to the bilateral CCAs was only 6.2% (1 of 16) (Kitamura, unpublished data). Therefore, comparison of the effects of 2VGO on SHRs and on WKY rats could facilitate our understanding of the clinical and pathological substrates of SIVD with small vessel pathology, with the caveat that the genetic background of SHR is not necessarily identical to that of WKY rats (St Lezin et al., 1992) .
Thus far, rats with several different backgrounds have been used for 2VO model, including Sprague-Dawley, Wistar and WKY rats. There may therefore have been discrepancies between rats in terms of the temporal CBF profile after 2VO. The relative CBF reduction from the baseline level in the current study was smaller than that found in Sprague-Dawley or Wistar rats but approximated that of WKY rats (Farkas et al., 2007) .
The ameroid constrictor has been applied to the porcine or canine coronary arteries to simulate atherosclerotic coronary heart disease (Litvak et al., 1957) , and the rabbit and rat femoral arteries to mimic chronic hindlimb ischemia (Tang et al., 2005) . However, this is the first report that the ameroid constrictor is applied to the CCA to replicate chronic cerebral hypoperfusion. Although the ameroid constrictor device achieves predictable gradual narrowing of the artery, the speed of arterial narrowing is dependent on both the size of ameroid constrictor and the diameter of arteries. As such, an in-vivo non-invasive imaging technique, such as CTA, may be applicable in the evaluation of the temporal change in carotid blood flow. Moreover, use of titanium for casing, instead of the stainless steel, will enable magnetic resonance imaging/angiography.
Rats of 12-14 weeks of age were used in the current study to reproduce chronic cerebral hypoperfusion. However, application of the ameroid constrictor to older animals for longer period should be considered given that SIVD is an age-related disease that develops over many years.
In conclusion, we have established a novel rat model that may more closely mimic cognitive impairment subsequent to selective white matter damage. The 2VGO model may therefore be adapted to explore possible treatments for SIVD.
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